# A Study Of PF-04554878 In Patients With Advanced Non-Hematologic Malignancies

> **NCT00787033** · PHASE1 · COMPLETED · sponsor: **Verastem, Inc.** · enrollment: 46 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** PF-04554878

## Key facts

- **NCT ID:** NCT00787033
- **Lead sponsor:** Verastem, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-03
- **Final completion:** 2012-02
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2017-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00787033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00787033, "A Study Of PF-04554878 In Patients With Advanced Non-Hematologic Malignancies". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00787033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*